Cited by 651Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsSpinal Cord Injury Research

The DOI matches its Crossref record; 130 of the 133 references it cites were found in a registry or an index.

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

Open access

Philips, Thomas, Robberecht, Wim·2011·The Lancet Neurology

DOI 10.1016/s1474-4422(11)70015-1

Open this paper in CoChat — free account

Abstract

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) are characterised by the appearance of reactive microglial and astroglial cells, a process referred to as neuroinflammation. In transgenic mouse models of mutant SOD1-associated familial ALS, reactive microglial cells and astrocytes actively contribute to the death of motor neurons. The biological processes that drive this glial reaction are complex and have both beneficial and deleterious effects on motor neurons. Therapeutic interventions targeting these cells are being explored. An improved understanding of the biological processes that cause neuroinflammation will help to define its medical importance and to identify the therapeutic potential of interfering with this reaction.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(11)70015-1

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341

Show all 133 references

Sorted by citations

Items 201–300 of 651

Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy
Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 50
Autophagy Modulators and Neuroinflammation
Cho, K. S., Lee, J. H., Cho, J., Cha, G., & Song, G. J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181031144605 · Cited by 49
Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1G93A Mouse Model of ALS by Enhancing Autophagic Flux
Zhang, X., Chen, S., Lu, K., Wang, F., Deng, J., Xu, Z., Wang, X., Zhou, Q., Le, W., & Zhao, Y. (2019) · Aging and Disease · doi:10.14336/ad.2019.0228 · Cited by 48
β2-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations
Laureys, G., Gerlo, S., Spooren, A., Demol, F., Keyser, J. D., & Aerts, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-21 · Cited by 47
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis
Marini, C., Cistaro, A., Campi, C., Calvo, A., Caponnetto, C., Nobili, F. M., Fania, P., Beltrametti, M. C., Moglia, C., Novi, G., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3440-3 · Cited by 47
Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106
Anderson, D. M., Cannavino, J., Li, H. Z., Anderson, K. M., Nelson, B. R., McAnally, J., Bezprozvannaya, S., Liu, Y., Lin, W., Liu, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608423113 · Cited by 46
Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts
Albrecht, D., Normandin, M. D., Shcherbinin, S., Wooten, D., Schwarz, A. J., Zürcher, N. R., Barth, V., Guehl, N. J., Akeju, O., Atassi, N., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178335 · Cited by 50
Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death
Ajmone‐Cat, M. A., Onori, A., Toselli, C., Stronati, E., Morlando, M., Bozzoni, I., Monni, E., Kokaia, Z., Lupo, G., Minghetti, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41040-4 · Cited by 46
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
Bowerman, M., Vincent, T., Scamps, F., Perrin, F. E., Camu, W., & Raoul, C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00214 · Cited by 46
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
Calma, A. D., Pavey, N., Menon, P., & Vucic, S. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001279 · Cited by 48
Role of astrocytes in major neurological disorders: The evidence and implications
Scuderi, C., Stecca, C., Iacomino, A., & Steardo, L. (2013) · IUBMB Life · doi:10.1002/iub.1223 · Cited by 48
The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis
Prell, T., Lautenschläger, J., Witte, O. W., Carrı̀, M. T., & Großkreutz, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08008.x · Cited by 50
Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
Baker, D. J., Blackburn, D. J., Keatinge, M., Sokhi, D. S., Viskaitis, P., Heath, P. R., Ferraiuolo, L., Kirby, J., & Shaw, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00410 · Cited by 48
Uptake of inorganic mercury by human locus ceruleus and corticomotor neurons: implications for amyotrophic lateral sclerosis
Pamphlett, R., & Jew, S. K. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-13 · Cited by 47
Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose
Massenzio, F., Peña‐Altamira, E., Petralla, S., Virgili, M., Zuccheri, G., Miti, A., Polazzi, E., Mengoni, I., Piffaretti, D., & Monti, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.013 · Cited by 47
Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis
Dodge, J. C., Yu, J., Sardi, S. P., & Shihabuddin, L. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-80378-y · Cited by 46
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 50
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
Jiménez-Villegas, J., Ferraiuolo, L., Mead, R. J., Shaw, P. J., Cuadrado, A., & Rojo, A. I. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.022 · Cited by 44
Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis
Shang, H., Wei, Q., Hou, Y., Zhang, L., Ou, R., Cao, B., & Chen, Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322476 · Cited by 45
EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
Sluter, M. N., Hou, R., Li, L., Yasmen, N., Yu, Y., Liu, J., & Jiang, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00816 · Cited by 44
Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes
Martorana, F., Guidotti, G., Brambilla, L., & Rossi, D. (2015) · Neural Plasticity · doi:10.1155/2015/381964 · Cited by 45
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrı̀, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 44
Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target
Natunen, T., Gynther, M., Rostalski, H., Jaako, K., & Jalkanen, A. J. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13094 · Cited by 44
Role of Oxidative Stress on the Etiology and Pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and Its Relation with the Enteric Nervous System
López‐Pingarrón, L., Almeida, H., Soria-Aznar, M., Reyes-Gonzales, M. C., Terrón, M. P., & García, J. J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040217 · Cited by 46
Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
Rauskolb, S., Dombert, B., & Sendtner, M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.007 · Cited by 45
Short-term air pollution exposure and emergency department visits for amyotrophic lateral sclerosis: A time-stratified case-crossover analysis
Myung, W., Lee, H., & Kim, H. (2019) · Environment International · doi:10.1016/j.envint.2018.12.042 · Cited by 42
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
Guidotti, G., Scarlata, C., Brambilla, L., & Rossi, D. (2021) · Cells · doi:10.3390/cells10030518 · Cited by 42
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
Xie, M., Pallegar, P. N., Parusel, S., Nguyen, A. T., & Wu, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00665-w · Cited by 43
Blockade of Gap Junction Hemichannel Protects Secondary Spinal Cord Injury from Activated Microglia-Mediated Glutamate Exitoneurotoxicity
Umebayashi, D., Natsume, A., Takeuchi, H., Hara, M., Nishimura, Y., Fukuyama, R., Sumiyoshi, N., & Wakabayashi, T. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3223 · Cited by 41
Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 44
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Conte, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137135 · Cited by 42
The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa
Ngarka, L., Fodjo, J. N. S., Aly, E., Masocha, W., & NJAMNSHI, A. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803475 · Cited by 46
State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model
Kim, R. B., Irvin, C. W., Tilva, K. R., & Mitchell, C. S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1047455 · Cited by 42
Ghrelin Protects Spinal Cord Motoneurons Against Chronic Glutamate Excitotoxicity by Inhibiting Microglial Activation
Lee, S., Kim, Y., Li, E., & Park, S. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.1.43 · Cited by 41
The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains
Stefano, M. E. D., & Herrero, M. T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.08.002 · Cited by 42
HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases
Matsye, P. D., Zheng, L., Si, Y., Kim, S., Luo, W., Crossman, D. K., Bratcher, P. E., & King, P. H. (2017) · Glia · doi:10.1002/glia.23137 · Cited by 44
Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis
Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 41
Neuroprotective effects of acetyl- l -carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor
Kazak, F., & Yarım, G. F. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.059 · Cited by 43
Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age
Ayton, S., Janelidze, S., Roberts, B. R., Palmqvist, S., Kalinowski, P., Diouf, I., Belaidi, A. A., Stomrud, E., Bush, A. I., & Hansson, O. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101904 · Cited by 43
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats
Bucher, T., Dubreil, L., Colle, M.-A., Maquigneau, M., Deniaud, J., Ledevin, M., Moullier, P., & Joussemet, B. (2014) · Gene Therapy · doi:10.1038/gt.2014.16 · Cited by 40
Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS
Eitan, C., Siany, A., Barkan, E., Olender, T., van Eijk, K. R., Moisse, M., Farhan, S. M. K., Danino, Y. M., Yanowski, E., Marmor-Kollet, H., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01040-6 · Cited by 38
Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
Garbuzova-Davis, S. N., Kurien, C., Haller, E. M., Eve, D. J., Navarro, S., Steiner, G. A., Mahendrasah, A., Hailu, S., Khatib, M., Boccio, K. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41747-4 · Cited by 40
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Si, Z., & Wang, X. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000324 · Cited by 42
Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD
Luan, W., Wright, A. L., Brown-Wright, H., Le, S., Gil, R. S., Martin, L. M. S., Ling, K., Jafar‐Nejad, P., Rigo, F., & Walker, A. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02036-9 · Cited by 41
Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease
Mani, S., Dubey, R., Lai, I., Babu, M. A., Tyagi, S., Swargiary, G., Mody, D., Singh, M., Agarwal, S., Iqbal, D., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220700 · Cited by 43
Angiotensin-Converting Enzyme Inhibitors and Amyotrophic Lateral Sclerosis Risk
Lin, F.-C., Tsai, C., Lee, J. K.-W., Wu, M., & Lee, C. T. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3367 · Cited by 39
Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases
Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 40
MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS
Kawaguchi, M., Yamamoto, T., Kato, Y., Inose, Y., & Shibata, N. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-21 · Cited by 39
The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes
Serrano, A., Donno, C., Giannetti, S., Perić, M., Anđjus, P. R., D’Ambrosi, N., & Michetti, F. (2017) · Mediators of Inflammation · doi:10.1155/2017/1626204 · Cited by 39
The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling
Fomin, V., Richard, P., Hoque, M., Li, C., Gu, Z., Fissore-O'Leary, M., Tian, B., Prives, C. L., & Manley, J. L. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00155-18 · Cited by 44
Motoneuronal and muscle-selective removal of ALS-related misfolded proteins
Crippa, V., Galbiati, M., Boncoraglio, A., Rusmini, P., Onesto, E., Giorgetti, E., Cristofani, R., Zito, A., & Poletti, A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130118 · Cited by 41
Neuroprotective agents target molecular mechanisms of disease in ALS
Zhu, Y., Fotinos, A., Mao, L. L. J., Atassi, N., Zhou, E., Ahmad, S., Guan, Y., Berry, J. D., Cudkowicz, M., & Wang, X. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.016 · Cited by 39
Dynamic secondary degeneration in the spinal cord and ventral root after a focal cerebral infarction among hypertensive rats
Dang, G., Chen, X., Chen, Y., Zhao, Y., Ouyang, F., & Zeng, J. (2016) · Scientific Reports · doi:10.1038/srep22655 · Cited by 38
Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
Cieślak, M., Roszek, K., & Wujak, M. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9633-4 · Cited by 38
Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosis
Zhang, C., Wang, H., Liang, W., Yang, Y., Cong, C., Wang, Y., Wang, S., Wang, X., Wang, D., Huo, D., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105457 · Cited by 38
Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes
Bassett, T., Bach, P., & Chan, H. M. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.10.003 · Cited by 38
Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model
Sun, H., Hou, Z., Yang, H., Meng, M., Li, P., Zou, Q., Yang, L., Chen, Y., Chai, H., Zhong, H., et al. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1903-z · Cited by 38
Targeting TRPs in Neurodegenerative Disorders
Takada, Y., Numata, T., & Mori, Y. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313030009 · Cited by 37
Synaptic Failure: Focus in an Integrative View of ALS
Casas, C., Manzano, R., Vaz, A. R., Osta, R., & Brites, D. M. T. O. (2015) · Brain Plasticity · doi:10.3233/bpl-140001 · Cited by 39
Expression profile of pattern recognition receptors in skeletal muscle of SOD1 (G93A) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients
Lehmann, S., Esch, E., Hartmann, P., Goswami, A., Nikolin, S., Weis, J., Beyer, C., & Johann, S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12483 · Cited by 41
Comparison of sirtuin 3 levels in ALS and Huntington's disease-differential effects in human tissue samples vs. transgenic mouse models
Buck, E., Bayer, H., Lindenberg, K. S., Hanselmann, J., Pasquarelli, N., Ludolph, A. C., Weydt, P., & Witting, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00156 · Cited by 36
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1G93A mice
nther, R. G. ⁄., Saal, K., Suhr, M., Scheer, D., Koch, J. C., Bähr, M., Lingor, P., & Tönges, L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00304 · Cited by 36
YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Andrés‐Benito, P., Domínguez, R., Colomina, M. J., Llorens, F., Povedano, M., & Ferrer, I. (2018) · Aging · doi:10.18632/aging.101551 · Cited by 37
The regulation of the small heat shock protein B8 in misfolding protein diseases causing motoneuronal and muscle cell death
Cristofani, R., Rusmini, P., Galbiati, M., Cicardi, M. E., Ferrari, V., Tedesco, B., Casarotto, E., Chierichetti, M., Messi, E., Piccolella, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00796 · Cited by 35
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies
Al-Khayri, J. M., Ravindran, M., Banadka, A., Devaiah, V. C., Priya, K., Nagella, P., & Kukkemane, K. (2024) · Pharmaceuticals · doi:10.3390/ph17101391 · Cited by 42
CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression.
Valente, T., Straccia, M., Gresa-arribas, N., Dentesano, G., Tusell, J. M., Serratosa, J., Mancera, P., Solà, C., & Saura, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.007 · Cited by 35
The Synthesis of α,α-Disubstituted α-Amino Acids via Ichikawa Rearrangement
Szcześniak, P., Pieczykolan, M., & Stecko, S. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02628 · Cited by 34
Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice
Blasco, A., Gras, S., Mòdol‐Caballero, G., Tarabal, O., Casanovas, A., Piedrafita, L., Barranco, A., Das, T., Pereira, S. L., Navarro, X., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12599 · Cited by 36
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex
Petrozziello, T., Mills, A. N., Vaine, C. A., Penney, E. B., Fernandez‐Cerado, C., Legarda, G. P., Velasco-Andrada, M. S., Acuña, P. J., Ang, M. A. C., Muñoz, E. L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105032 · Cited by 35
Erythropoietin modulates the immune-inflammatory response of a SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)
Noh, M., Cho, K., Kim, H., Kim, S.-M., & Kim, S. H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.001 · Cited by 34
White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis
Dimond, D., Ishaque, A. H., Chenji, S., Mah, D., Chen, Z., Seres, P., Beaulieu, C., & Kalra, S. (2016) · Human Brain Mapping · doi:10.1002/hbm.23452 · Cited by 36
Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins
Strickland, M. R., Rau, M. J., Summers, B., Basore, K., Wulf, J., Jiang, H., Chen, Y., Ulrich, J. D., Randolph, G. J., Zhang, R., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.018 · Cited by 28
A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
Lind, A., Wu, D., Freyhult, E., Bodolea, C., Ekegren, T., Larsson, A. O., Gustafsson, M. G., Katila, L., Bergquist, J., Gordh, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149821 · Cited by 33
Stem cells for ALS: An overview of possible therapeutic approaches
Czarzasta, J., Habich, A., Siwek, T., Czapliński, A., Maksymowicz, W., & Wojtkiewicz, J. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.003 · Cited by 33
Immune system alterations in amyotrophic lateral sclerosis
Hovden, H., Frederiksen, J. L., & Pedersen, S. W. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12125 · Cited by 36
Drugs in clinical development for the treatment of amyotrophic lateral sclerosis
Martı́nez, A., Palomo, V., Pérez, D. I., & Gil, C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1302426 · Cited by 36
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
Argueti-Ostrovsky, S., Barel, S., Kahn, J., & Israelson, A. (2024) · Biomolecules · doi:10.3390/biom15010033 · Cited by 31
TNF-α modulation by rice bran peptides: implications for gut microbiota stability and cognitive health in aging
Mu, J., Lin, Q., Wang, S., Chen, M., Wang, J., Chen, Y., Li, Y., & Liang, Y. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00830-7 · Cited by 37
The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 34
Glial Activation and Central Synapse Loss, but Not Motoneuron Degeneration, Are Prevented by the Sigma-1 Receptor Agonist PRE-084 in the Smn2B/− Mouse Model of Spinal Muscular Atrophy
Cerveró, C., Blasco, A., Tarabal, O., Casanovas, A., Piedrafita, L., Navarro, X., Esquerda, J. E., & Calderó, J. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly033 · Cited by 34
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis
Sala, A., Iaccarino, L., Fania, P., Vanoli, E. G., Fallanca, F., Pagnini, C., Cerami, C., Calvo, A., Canosa, A., Pagani, M., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4246-2 · Cited by 33
Thalamic neurometabolite alterations in patients with knee osteoarthritis before and after total knee replacement
Weerasekera, A., Morrissey, E. J., Kim, M., Saha, A., Lin, Y., Alshelh, Z., Torrado-Carvajal, Á., Albrecht, D., Akeju, O., Kwon, Y., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002198 · Cited by 35
Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs
Jin, M., Akgün, K., Ziemssen, T., Kipp, M., Günther, R., & Hermann, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158042 · Cited by 32
Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression
Jeyachandran, A., Mertens, B., McKissick, E. A., & Mitchell, C. S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00462 · Cited by 36
Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study
Zhang, L., Zhuang, Z., Zhang, G., Huang, T., & Fan, D. (2022) · BMC Neurology · doi:10.1186/s12883-021-02522-z · Cited by 31
Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis
Nonneman, A., Criem, N., Lewandowski, S. A., Nuyts, R., Thal, D. R., Pfrieger, F. W., Ravits, J., Damme, P. V., Zwijsen, A., Bosch, L. V. D., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.012 · Cited by 31
Self-citation
Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo
Xue, Y. C., Ruller, C. M., Fung, G., Mohamud, Y., Deng, H., Liu, H., Zhang, J., Feuer, R., & Luo, H. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.013 · Cited by 30
Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis
Schreiber, S., Schreiber, F., Garz, C., Dębska–Vielhaber, G., Assmann, A., Perosa, V., Petri, S., Dengler, R., Nestor, P. J., & Vielhaber, S. (2019) · Muscle & Nerve · doi:10.1002/mus.26444 · Cited by 30
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis
Goris, A., van Setten, J., Diekstra, F. P., Ripke, S., Patsopoulos, N. A., Sawcer, S. J., van Es, M. A., Andersen, P. M., Melki, J., Meininger, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt574 · Cited by 30
Self-citation
Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis
Watanabe-Matsumoto, S., Moriwaki, Y., Okuda, T., Ohara, S., Yamanaka, K., Abe, Y., Yasui, M., & Misawa, H. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.11.001 · Cited by 31
Intravenous injection of l-BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson–dementia complex
Tian, K.-W., Jiang, H., Wang, B., Zhang, F., & Han, S. (2015) · Toxicology Research · doi:10.1039/c5tx00272a · Cited by 29
Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
Herrando‐Grabulosa, M., Mulet‐Lazaro, R., Pujol, A., Mas, J. M., Navarro, X., Aloy, P., Coma, M., & Casas, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147626 · Cited by 30
Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study
Li, D., Ren, H., Jeromin, A., Liu, M., Shen, D., Tai, H., Ding, Q., Li, X., & Cui, L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00726 · Cited by 30
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 30
Oxidative Stress, Neuroinflammation, and Neurodegeneration
Gao, H., Zhou, H., & Hong, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_5 · Cited by 30
Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis
Yan, J., Xu, Y., Zhang, L., Zhao, H., Jin, L., Liu, W., Weng, L., Zuo-han, L., & Chen, L. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.194656 · Cited by 30
Advanced therapeutic strategies targeting microglia: beyond neuroinflammation
Kwon, M. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01406-1 · Cited by 29
Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity
Mimic, S., Aru, B., Pehlivanoğlu, C., Sleiman, H., Anđjus, P. R., & Demirel, G. Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1277399 · Cited by 29
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 transgenic mice
Sieverding, K., Ulmer, J., Bruno, C., Satoh, T., Tsao, W., Freischmidt, A., Akira, S., Wong, P. C., Ludolph, A. C., Danzer, K. M., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113496 · Cited by 30
Microglia in ALS: Insights into Mechanisms and Therapeutic Potential
Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 32

Authors: Philips, T., & Robberecht, W.
Affiliations: KU Leuven (BE)
Corresponding author: Robberecht, Wim
ORCID: Philips, Thomas
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2011-03
Volume: 10
Issue: 3
Pages: 253-263
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(11)70015-1
OpenAlex: W2144507462
Cited by: 646
References: 133
Citations by year: 2026: 25 · 2025: 24 · 2024: 39 · 2023: 45 · 2022: 38 · 2021: 44 · 2020: 45 · 2019: 41 · 2018: 43 · 2017: 58 · 2016: 44 · 2015: 41 · 2014: 52 · 2013: 53 · 2012: 40
FWCI: 6.36
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
Keywords: amyotrophic lateral sclerosis, neuroinflammation, glial activation, microglia, astrocytes, motor neuron degeneration, neurodegeneration
MeSH terms: Amyotrophic Lateral Sclerosis, Animals, Humans, Inflammation, Neuroglia, T-Lymphocytes, Signal Transduction, Motor Neuron Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks